Moderna has launched a lawsuit against pharmaceutical giant Pfizer and its German partner BioNTech for alleged patent infringement in relation to the covid-19 vaccine developed. The UK firm claims that Pfizer and BioNTech utilised technology patented by Moderna years before the pandemic.
The lawsuit was filed jointly in a Massachusetts district court and a regional court in Dusseldorf, Germany.
A news release from the company reads: “Moderna believes that Pfizer and BioNTech’s COVID-19 vaccine Comirnaty infringes patents Moderna filed between 2010 and 2016 covering Moderna’s foundational mRNA technology. This groundbreaking technology was critical to the development of Moderna’s own mRNA COVID-19 vaccine, Spikevax. Pfizer and BioNTech copied this technology, without Moderna’s permission, to make Comirnaty.”
Moderna files lawsuits against Pfizer and BioNTech claiming patent infringement over Covid-19 vaccine technology https://t.co/QRN3BjRHwK
Coronavirus restrictions have eased throughout 2022 to the point where society has essentially returned to pre-pandemic conditions, but as we head towards the winter months there is concern that the cold weather could bring a resurgence in the virus.
Earlier this week it was announced that the United States would be rolling out an updated version of the covid-19 booster vaccine to better protect against Omicron and other variants. With this in mind, is there any danger that the lawsuit to curb the distribution of the life-saving shots?
The press release from Moderna made clear that the company was not aiming to impose a blanket ban on the Pfizer-BioNTech vaccine or to prevent future sales. However it does state that they believe the fight against covid-19 has “entered a new phase” in which “vaccine supply is no longer a barrier to access in many parts of the world.”
The statement reads: “Moderna expected companies such as Pfizer and BioNTech to respect its intellectual property rights and would consider a commercially reasonable license should they request one… Pfizer and BioNTech have failed to do so.”
The point of contention is the use of mRNA technology which allowed developers to create a vaccine effective against covid-19 in record time. That technology, Moderna claim, was developed by their scientists many years before covid-19, to protect against Middle East Respiratory Syndrome (MERS).
Moderna has said that it will not seek damages for any activity before 8 March 2022, the point at which the company judges that the availability of covid-19 stopped being a limiting factor.
To be able to comment you must be registered and logged in. Forgot password?
Suscribe to our newsletters
Enjoy live and on-demand online sports on DAZN. Activate your account
NBA Pass League
Now you can watch the entire NBA season or your favorite teams on streaming.
Moderna sues Pfizer and BioNTech over patented mRNA technology used in covid-19 vaccine – AS USA